Integrating inflammatory serum biomarkers into a risk calculator for prostate cancer detection
Improved prostate cancer detection methods would avoid over-diagnosis of clinically indolent disease informing appropriate treatment decisions. The aims of this study were to investigate the role of a panel of Inflammation biomarkers to inform the need for a biopsy to diagnose prostate cancer. Perip...
Saved in:
| Published in | Scientific reports Vol. 11; no. 1; pp. 2525 - 8 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
28.01.2021
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2045-2322 2045-2322 |
| DOI | 10.1038/s41598-021-81965-3 |
Cover
Loading…
| Abstract | Improved prostate cancer detection methods would avoid over-diagnosis of clinically indolent disease informing appropriate treatment decisions. The aims of this study were to investigate the role of a panel of Inflammation biomarkers to inform the need for a biopsy to diagnose prostate cancer. Peripheral blood serum obtained from 436 men undergoing transrectal ultrasound guided biopsy were assessed for a panel of 18 inflammatory serum biomarkers in addition to Total and Free Prostate Specific Antigen (PSA). This panel was integrated into a previously developed Irish clinical risk calculator (IPRC) for the detection of prostate cancer and high-grade prostate cancer (Gleason Score ≥ 7). Using logistic regression and multinomial regression methods, two models (Logst-RC and Multi-RC) were developed considering linear and nonlinear effects of the panel in conjunction with clinical and demographic parameters for determination of the two endpoints. Both models significantly improved the predictive ability of the clinical model for detection of prostate cancer (from 0.656 to 0.731 for Logst-RC and 0.713 for Multi-RC) and high-grade prostate cancer (from 0.716 to 0.785 for Logst-RC and 0.767 for Multi-RC) and demonstrated higher clinical net benefit. This improved discriminatory power and clinical utility may allow for individualised risk stratification improving clinical decision making. |
|---|---|
| AbstractList | Abstract Improved prostate cancer detection methods would avoid over-diagnosis of clinically indolent disease informing appropriate treatment decisions. The aims of this study were to investigate the role of a panel of Inflammation biomarkers to inform the need for a biopsy to diagnose prostate cancer. Peripheral blood serum obtained from 436 men undergoing transrectal ultrasound guided biopsy were assessed for a panel of 18 inflammatory serum biomarkers in addition to Total and Free Prostate Specific Antigen (PSA). This panel was integrated into a previously developed Irish clinical risk calculator (IPRC) for the detection of prostate cancer and high-grade prostate cancer (Gleason Score ≥ 7). Using logistic regression and multinomial regression methods, two models (Logst-RC and Multi-RC) were developed considering linear and nonlinear effects of the panel in conjunction with clinical and demographic parameters for determination of the two endpoints. Both models significantly improved the predictive ability of the clinical model for detection of prostate cancer (from 0.656 to 0.731 for Logst-RC and 0.713 for Multi-RC) and high-grade prostate cancer (from 0.716 to 0.785 for Logst-RC and 0.767 for Multi-RC) and demonstrated higher clinical net benefit. This improved discriminatory power and clinical utility may allow for individualised risk stratification improving clinical decision making. Improved prostate cancer detection methods would avoid over-diagnosis of clinically indolent disease informing appropriate treatment decisions. The aims of this study were to investigate the role of a panel of Inflammation biomarkers to inform the need for a biopsy to diagnose prostate cancer. Peripheral blood serum obtained from 436 men undergoing transrectal ultrasound guided biopsy were assessed for a panel of 18 inflammatory serum biomarkers in addition to Total and Free Prostate Specific Antigen (PSA). This panel was integrated into a previously developed Irish clinical risk calculator (IPRC) for the detection of prostate cancer and high-grade prostate cancer (Gleason Score ≥ 7). Using logistic regression and multinomial regression methods, two models (Logst-RC and Multi-RC) were developed considering linear and nonlinear effects of the panel in conjunction with clinical and demographic parameters for determination of the two endpoints. Both models significantly improved the predictive ability of the clinical model for detection of prostate cancer (from 0.656 to 0.731 for Logst-RC and 0.713 for Multi-RC) and high-grade prostate cancer (from 0.716 to 0.785 for Logst-RC and 0.767 for Multi-RC) and demonstrated higher clinical net benefit. This improved discriminatory power and clinical utility may allow for individualised risk stratification improving clinical decision making.Improved prostate cancer detection methods would avoid over-diagnosis of clinically indolent disease informing appropriate treatment decisions. The aims of this study were to investigate the role of a panel of Inflammation biomarkers to inform the need for a biopsy to diagnose prostate cancer. Peripheral blood serum obtained from 436 men undergoing transrectal ultrasound guided biopsy were assessed for a panel of 18 inflammatory serum biomarkers in addition to Total and Free Prostate Specific Antigen (PSA). This panel was integrated into a previously developed Irish clinical risk calculator (IPRC) for the detection of prostate cancer and high-grade prostate cancer (Gleason Score ≥ 7). Using logistic regression and multinomial regression methods, two models (Logst-RC and Multi-RC) were developed considering linear and nonlinear effects of the panel in conjunction with clinical and demographic parameters for determination of the two endpoints. Both models significantly improved the predictive ability of the clinical model for detection of prostate cancer (from 0.656 to 0.731 for Logst-RC and 0.713 for Multi-RC) and high-grade prostate cancer (from 0.716 to 0.785 for Logst-RC and 0.767 for Multi-RC) and demonstrated higher clinical net benefit. This improved discriminatory power and clinical utility may allow for individualised risk stratification improving clinical decision making. Improved prostate cancer detection methods would avoid over-diagnosis of clinically indolent disease informing appropriate treatment decisions. The aims of this study were to investigate the role of a panel of Inflammation biomarkers to inform the need for a biopsy to diagnose prostate cancer. Peripheral blood serum obtained from 436 men undergoing transrectal ultrasound guided biopsy were assessed for a panel of 18 inflammatory serum biomarkers in addition to Total and Free Prostate Specific Antigen (PSA). This panel was integrated into a previously developed Irish clinical risk calculator (IPRC) for the detection of prostate cancer and high-grade prostate cancer (Gleason Score ≥ 7). Using logistic regression and multinomial regression methods, two models (Logst-RC and Multi-RC) were developed considering linear and nonlinear effects of the panel in conjunction with clinical and demographic parameters for determination of the two endpoints. Both models significantly improved the predictive ability of the clinical model for detection of prostate cancer (from 0.656 to 0.731 for Logst-RC and 0.713 for Multi-RC) and high-grade prostate cancer (from 0.716 to 0.785 for Logst-RC and 0.767 for Multi-RC) and demonstrated higher clinical net benefit. This improved discriminatory power and clinical utility may allow for individualised risk stratification improving clinical decision making. |
| ArticleNumber | 2525 |
| Author | Watson, Ronald William Perry, Antoinette Sabrina Jalali, Amirhossein Martin, Kenneth Kitching, Michael Murphy, Thomas Brendan Richardson, Ciaran FitzGerald, Stephen Peter |
| Author_xml | – sequence: 1 givenname: Amirhossein surname: Jalali fullname: Jalali, Amirhossein email: amir.jalali@ucc.ie organization: UCD Conway Institute of Biomedical and Biomolecular Science, UCD School of Medicine, University College Dublin, School of Mathematical Sciences, University College Cork – sequence: 2 givenname: Michael surname: Kitching fullname: Kitching, Michael organization: UCD Conway Institute of Biomedical and Biomolecular Science, UCD School of Biology and Environmental Science, University College Dublin – sequence: 3 givenname: Kenneth surname: Martin fullname: Martin, Kenneth organization: Randox Teoranta, Co – sequence: 4 givenname: Ciaran surname: Richardson fullname: Richardson, Ciaran organization: Randox Teoranta, Co – sequence: 5 givenname: Thomas Brendan surname: Murphy fullname: Murphy, Thomas Brendan organization: School of Mathematics and Statistics, University College Dublin – sequence: 6 givenname: Stephen Peter surname: FitzGerald fullname: FitzGerald, Stephen Peter organization: Randox Laboratories Ltd – sequence: 7 givenname: Ronald William surname: Watson fullname: Watson, Ronald William organization: UCD Conway Institute of Biomedical and Biomolecular Science, UCD School of Medicine, University College Dublin – sequence: 8 givenname: Antoinette Sabrina surname: Perry fullname: Perry, Antoinette Sabrina organization: UCD Conway Institute of Biomedical and Biomolecular Science, UCD School of Biology and Environmental Science, University College Dublin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33510263$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uk1vFSEUJabG1to_4MJM4sbNKF_DMBsT0_jxkiZudCthmMvI6ww8gWnSfy_TabXtoiQEuJxzOOGel-jIBw8IvSb4PcFMfkicNJ2sMSW1JJ1oavYMnVDMm5oySo_u7Y_RWUp7XEZDO066F-iYsYZgKtgJ-rXzGcaos_Nj5byd9DzrHOJ1lSAuc9W7MOt4CTGV2xwqXUWXLiujJ7NMK7CyZR5iSFlnKHVvIFYDZDDZBf8KPbd6SnB2u56in18-_zj_Vl98_7o7_3RRm4bjXAtje8CmXU9UGssHxozFoqM9pwOh2grSEsuYkMbgBjpiQAJuh460hjWMnaLdpjsEvVeH6IrpaxW0UzeFEEelY3ZmAiUMYX03iF7wrohT3ffcCmgttIwDX7U-blqHpZ9hMOBz1NMD0Yc33v1WY7hSreScClIE3t0KxPBngZTV7JKBadIewpIU5ZJJwrBc33r7CLoPS_Tlq1YUZU0rKC6oN_cd_bNy18YCkBvAlEakCFYZV_pRGlAMukkRrNbQqC00qoRG3YRGrVT6iHqn_iSJbaRUwH6E-N_2E6y_zcfVEg |
| CitedBy_id | crossref_primary_10_1038_s41420_021_00766_9 crossref_primary_10_1109_TMBMC_2023_3274112 crossref_primary_10_1177_15330338241290029 crossref_primary_10_3390_ijms252413720 crossref_primary_10_1038_s41391_024_00852_w crossref_primary_10_3390_ijms25010157 crossref_primary_10_1021_acs_langmuir_1c00867 |
| Cites_doi | 10.1016/j.eururo.2014.10.021 10.1177/1756287213513488 10.1111/bju.13143 10.1016/j.eururo.2013.05.049 10.1016/j.ejca.2010.11.012 10.1161/CIRCULATIONAHA.116.022802 10.1016/j.eururo.2012.11.014 10.1038/bjc.2014.606 10.1186/s12911-020-01174-2 10.1001/jamacardio.2016.3311 10.1007/s00345-011-0818-5 10.1016/j.eururo.2011.11.012 10.1073/pnas.1318157111 10.1155/2018/3852401 10.1021/pr070409o 10.1016/j.thromres.2011.12.004 10.1007/978-3-0348-0837-8_7 10.17219/acem/62120 10.1056/NEJMoa0810084 10.1111/j.1464-410X.2011.10611.x 10.1038/s41416-019-0458-x 10.1080/15321810600862298 10.1016/S0140-6736(16)32401-1 10.1177/0272989X06295361 10.1038/s41391-017-0008-7 10.1126/scitranslmed.3003180 10.1016/j.celrep.2016.11.010 10.1016/j.urology.2014.02.035 10.2307/2531595 10.1016/S0959-8049(02)00218-6 10.1186/s41512-019-0064-7 10.1038/nrurol.2017.167 10.1007/978-3-030-16399-0 10.1016/j.clgc.2018.09.022 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.1038/s41598-021-81965-3 |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni) Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database CrossRef |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_6c13b9d6b64942d2abb4f6e7fe734e43 PMC7844261 33510263 10_1038_s41598_021_81965_3 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Enterprise Ireland grantid: 20160464 funderid: http://dx.doi.org/10.13039/501100001588 – fundername: Enterprise Ireland grantid: 20160464 – fundername: ; grantid: 20160464 |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT NPM 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c540t-6cfbe0c7c54028cf4d33cf0692b42d12af6171f3368cc05e91ce8e07d917c3533 |
| IEDL.DBID | M48 |
| ISSN | 2045-2322 |
| IngestDate | Wed Aug 27 01:29:34 EDT 2025 Thu Aug 21 14:03:17 EDT 2025 Fri Jul 11 13:14:49 EDT 2025 Wed Aug 13 08:05:25 EDT 2025 Thu Jan 02 22:57:41 EST 2025 Tue Jul 01 01:07:20 EDT 2025 Thu Apr 24 23:01:39 EDT 2025 Fri Feb 21 02:39:01 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c540t-6cfbe0c7c54028cf4d33cf0692b42d12af6171f3368cc05e91ce8e07d917c3533 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-021-81965-3 |
| PMID | 33510263 |
| PQID | 2482357620 |
| PQPubID | 2041939 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6c13b9d6b64942d2abb4f6e7fe734e43 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7844261 proquest_miscellaneous_2483813083 proquest_journals_2482357620 pubmed_primary_33510263 crossref_citationtrail_10_1038_s41598_021_81965_3 crossref_primary_10_1038_s41598_021_81965_3 springer_journals_10_1038_s41598_021_81965_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-28 |
| PublicationDateYYYYMMDD | 2021-01-28 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-28 day: 28 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2021 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Ahmed, Bosaily, Brown, Gabe, Kaplan, Parmar, Collaco-Moraes, Ward, Hindley, Freeman, Kirkham (CR5) 2017; 389 McAleer, McPhillips, FitzGerald, McConnell, Rodriguez (CR23) 2006; 27 van Vugt, Roobol, Busstra, Kil, Oomens, de Jong, Bangma, Steyerberg, Korfage (CR8) 2012; 109 Loeb, Catalona (CR13) 2014; 6 Ankerst, Hoefler, Bock, Goodman, Vickers, Hernandez, Sokoll, Sanda, Wei, Leach, Thompson (CR10) 2014; 83 Vickers, van Calster, Steyerberg (CR29) 2019; 3 Loeb, Vellekoop, Ahmed, Catto, Emberton, Nam, Rosario, Scattoni, Lotan (CR2) 2013; 64 Ma, Ren, Dai, Wu, Ji, Xu (CR34) 2017; 26 Agresti (CR36) 2003 Ruff, Giugliano, Braunwald, Murphy, Brown, Jarolim, Mercuri, Antman, Morrow (CR6) 2016; 1 van Vugt, Roobol, Kranse, Määttänen, Finne, Hugosson, Bangma, Schröder, Steyerberg (CR3) 2011; 47 Ahmad, Ormiston-Smith, Sasieni (CR17) 2015; 112 Foley, Gorman, Sharifi, Murphy, Moore, Tuzova, Perry, Murphy, Lundon, Watson (CR15) 2016; 117 O’hanlon, Fitzsimons, Lynch, Tormey, Malone, Given (CR33) 2002; 38 Leyten, Hessels, Jannink, Smit, de Jong, Cornel, de Reijke, Vergunst, Kil, Knipscheer, van Oort (CR16) 2014; 65 Vickers, Elkin (CR27) 2006; 26 Jalali, Foley, Maweni, Murphy, Lundon, Lynch, Power, O’Brien, O’Malley, Galvin, Durkan (CR25) 2020; 20 Oldgren, Hijazi, Lindbäck, Alexander, Connolly, Eikelboom, Ezekowitz, Granger, Hylek, Lopes, Siegbahn (CR7) 2016; 134 Roobol, van Vugt, Loeb, Zhu, Bul, Bangma, van Leenders, Steyerberg, Schröder (CR9) 2012; 61 Sfanos, Hempel, De Marzo (CR18) 2014 CR24 Watson, Salisbury, Banks, Whiting, Hamilton (CR19) 2019; 120 Vicier, Werner, Chipman, Harshman, Patil, Fichorova, Rider, Sanda, Mucci, Sweeney (CR35) 2019; 17 Kwon, Zhang, Ittmann, Xin (CR21) 2014; 111 FitzGerald, McConnell, Huxley (CR22) 2008; 7 Steyerberg (CR28) 2019 Prensner, Rubin, Wei, Chinnaiyan (CR1) 2012; 4 DeLong, DeLong, Clarke-Pearson (CR26) 1988; 44 Schröder, Hugosson, Roobol, Tammela, Ciatto, Nelen, Kwiatkowski, Lujan, Lilja, Zappa, Denis (CR4) 2009; 360 Liu, Grogan, Hieronymus, Hashimoto, Mottahedeh, Cheng, Zhang, Huang, Stoyanova, Park, Shkhyan (CR20) 2016; 17 Ankerst, Boeck, Freedland, Thompson, Cronin, Roobol, Hugosson, Jones, Kattan, Klein, Hamdy (CR11) 2012; 30 White, Shenoy, Tutrone, Karsh, Saltzstein, Harmon, Broyles, Roddy, Lofaro, Paoli, Denham (CR12) 2018; 21 Parekh, Punnen, Sjoberg, Asroff, Bailen, Cochran, Concepcion, David, Deck, Dumbadze, Gambla (CR14) 2015; 68 Dymicka-Piekarska, Guzinska-Ustymowicz, Kuklinski, Kemona (CR31) 2012; 129 Fryczkowski, Bułdak, Hejmo, Kukla, Żwirska-Korczala (CR32) 2018 Sfanos, Yegnasubramanian, Nelson, De Marzo (CR30) 2018; 15 JR Prensner (81965_CR1) 2012; 4 J White (81965_CR12) 2018; 21 FH Schröder (81965_CR4) 2009; 360 MJ Roobol (81965_CR9) 2012; 61 D McAleer (81965_CR23) 2006; 27 J Oldgren (81965_CR7) 2016; 134 AJ Vickers (81965_CR27) 2006; 26 X Liu (81965_CR20) 2016; 17 V Dymicka-Piekarska (81965_CR31) 2012; 129 KS Sfanos (81965_CR18) 2014 M Fryczkowski (81965_CR32) 2018 AJ Vickers (81965_CR29) 2019; 3 DM O’hanlon (81965_CR33) 2002; 38 HA van Vugt (81965_CR3) 2011; 47 C Vicier (81965_CR35) 2019; 17 EW Steyerberg (81965_CR28) 2019 DP Ankerst (81965_CR11) 2012; 30 HA van Vugt (81965_CR8) 2012; 109 A Jalali (81965_CR25) 2020; 20 AS Ahmad (81965_CR17) 2015; 112 A Agresti (81965_CR36) 2003 S Loeb (81965_CR2) 2013; 64 HU Ahmed (81965_CR5) 2017; 389 Y Ma (81965_CR34) 2017; 26 CT Ruff (81965_CR6) 2016; 1 RW Foley (81965_CR15) 2016; 117 SP FitzGerald (81965_CR22) 2008; 7 J Watson (81965_CR19) 2019; 120 OJ Kwon (81965_CR21) 2014; 111 S Loeb (81965_CR13) 2014; 6 DP Ankerst (81965_CR10) 2014; 83 81965_CR24 GH Leyten (81965_CR16) 2014; 65 ER DeLong (81965_CR26) 1988; 44 DJ Parekh (81965_CR14) 2015; 68 KS Sfanos (81965_CR30) 2018; 15 |
| References_xml | – volume: 68 start-page: 464 issue: 3 year: 2015 end-page: 470 ident: CR14 article-title: A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer publication-title: Eur. Urol. doi: 10.1016/j.eururo.2014.10.021 – volume: 6 start-page: 74 issue: 2 year: 2014 end-page: 77 ident: CR13 article-title: The Prostate Health Index: A new test for the detection of prostate cancer publication-title: Ther. Adv. Urol. doi: 10.1177/1756287213513488 – volume: 117 start-page: 409 issue: 3 year: 2016 end-page: 417 ident: CR15 article-title: Improving multivariable prostate cancer risk assessment using the Prostate Health Index publication-title: BJU Int. doi: 10.1111/bju.13143 – volume: 64 start-page: 876 issue: 6 year: 2013 end-page: 892 ident: CR2 article-title: Systematic review of complications of prostate biopsy publication-title: Eur. Urol. doi: 10.1016/j.eururo.2013.05.049 – volume: 47 start-page: 903 issue: 6 year: 2011 end-page: 909 ident: CR3 article-title: Prediction of prostate cancer in unscreened men: external validation of a risk calculator publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2010.11.012 – volume: 134 start-page: 1697 issue: 22 year: 2016 end-page: 1707 ident: CR7 article-title: Performance and validation of a novel biomarker-based stroke risk score for atrial fibrillation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.022802 – volume: 65 start-page: 534 issue: 3 year: 2014 end-page: 542 ident: CR16 article-title: Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer publication-title: Eur. Urol. doi: 10.1016/j.eururo.2012.11.014 – volume: 112 start-page: 943 issue: 5 year: 2015 end-page: 947 ident: CR17 article-title: Trends in the lifetime risk of developing cancer in Great Britain: Comparison of risk for those born from 1930 to 1960 publication-title: Br. J. Cancer doi: 10.1038/bjc.2014.606 – volume: 20 start-page: 1 issue: 1 year: 2020 end-page: 1 ident: CR25 article-title: A risk calculator to inform the need for a prostate biopsy: A rapid access clinic cohort publication-title: BMC Med. Inform. Decis. Mak. doi: 10.1186/s12911-020-01174-2 – volume: 1 start-page: 999 issue: 9 year: 2016 end-page: 1006 ident: CR6 article-title: Cardiovascular biomarker score and clinical outcomes in patients with atrial fibrillation: A subanalysis of the ENGAGE AF-TIMI 48 randomized clinical trial publication-title: JAMA Cardiol. doi: 10.1001/jamacardio.2016.3311 – volume: 30 start-page: 181 issue: 2 year: 2012 end-page: 187 ident: CR11 article-title: Evaluating the PCPT risk calculator in ten international biopsy cohorts: Results from the Prostate Biopsy Collaborative Group publication-title: World J. Urol. doi: 10.1007/s00345-011-0818-5 – volume: 61 start-page: 577 issue: 3 year: 2012 end-page: 583 ident: CR9 article-title: Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators publication-title: Eur. Urol. doi: 10.1016/j.eururo.2011.11.012 – volume: 111 start-page: E592 issue: 5 year: 2014 end-page: 600 ident: CR21 article-title: Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1318157111 – year: 2018 ident: CR32 article-title: Circulating levels of omentin, leptin, VEGF, and HGF and their clinical relevance with PSA marker in prostate cancer publication-title: Dis. Mark doi: 10.1155/2018/3852401 – volume: 7 start-page: 450 issue: 01 year: 2008 end-page: 455 ident: CR22 article-title: Simultaneous analysis of circulating human cytokines using a high-sensitivity cytokine biochip array publication-title: J. Proteome Res. doi: 10.1021/pr070409o – volume: 129 start-page: e47 issue: 4 year: 2012 end-page: 50 ident: CR31 article-title: Prognostic significance of adhesion molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients publication-title: Thromb. Res. doi: 10.1016/j.thromres.2011.12.004 – start-page: 153 year: 2014 end-page: 181 ident: CR18 publication-title: The Role of Inflammation in Prostate Cancer doi: 10.1007/978-3-0348-0837-8_7 – volume: 26 start-page: 421 issue: 3 year: 2017 end-page: 426 ident: CR34 article-title: IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients publication-title: Adv. Clin. Exp. Med. doi: 10.17219/acem/62120 – volume: 360 start-page: 1320 issue: 13 year: 2009 end-page: 1328 ident: CR4 article-title: Screening and prostate-cancer mortality in a randomized European study publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0810084 – volume: 109 start-page: 1480 issue: 10 year: 2012 end-page: 1488 ident: CR8 article-title: Compliance with biopsy recommendations of a prostate cancer risk calculator publication-title: BJU Int. doi: 10.1111/j.1464-410X.2011.10611.x – volume: 120 start-page: 1045 issue: 11 year: 2019 end-page: 1051 ident: CR19 article-title: Predictive value of inflammatory markers for cancer diagnosis in primary care: A prospective cohort study using electronic health records publication-title: Br. J. Cancer doi: 10.1038/s41416-019-0458-x – volume: 27 start-page: 363 issue: 4 year: 2006 end-page: 378 ident: CR23 article-title: Application of evidence InvestigatorTM for the simultaneous measurement of soluble adhesion molecules: L-, P-, E-Selectins, VCAM-1, ICAM-1 in a Biochip Platform publication-title: J. Immunoassay Immunochem. doi: 10.1080/15321810600862298 – volume: 389 start-page: 815 issue: 10071 year: 2017 end-page: 822 ident: CR5 article-title: Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): A paired validating confirmatory study publication-title: The Lancet. doi: 10.1016/S0140-6736(16)32401-1 – volume: 26 start-page: 565 issue: 6 year: 2006 end-page: 574 ident: CR27 article-title: Decision curve analysis: A novel method for evaluating prediction models publication-title: Med. Decis. Making doi: 10.1177/0272989X06295361 – volume: 21 start-page: 78 issue: 1 year: 2018 end-page: 84 ident: CR12 article-title: Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting publication-title: Prostate Cancer Prostatic Dis. doi: 10.1038/s41391-017-0008-7 – volume: 4 start-page: 127rv3 issue: 127 year: 2012 ident: CR1 article-title: Beyond PSA: The next generation of prostate cancer biomarkers publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3003180 – volume: 17 start-page: 2596 issue: 10 year: 2016 end-page: 2606 ident: CR20 article-title: Low CD38 identifies progenitor-like inflammation-associated luminal cells that can initiate human prostate cancer and predict poor outcome publication-title: Cell Rep. doi: 10.1016/j.celrep.2016.11.010 – volume: 83 start-page: 1362 issue: 6 year: 2014 end-page: 1368 ident: CR10 article-title: Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low-vs high-grade prostate cancer publication-title: Urology doi: 10.1016/j.urology.2014.02.035 – volume: 44 start-page: 837 year: 1988 end-page: 845 ident: CR26 article-title: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach publication-title: Biometrics doi: 10.2307/2531595 – volume: 38 start-page: 2252 issue: 17 year: 2002 end-page: 2257 ident: CR33 article-title: Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma publication-title: Eur. J. Cancer doi: 10.1016/S0959-8049(02)00218-6 – year: 2003 ident: CR36 publication-title: Categorical Data Analysis – volume: 3 start-page: 1 issue: 1 year: 2019 end-page: 8 ident: CR29 article-title: A simple, step-by-step guide to interpreting decision curve analysis publication-title: Diagn. Progn. Res. doi: 10.1186/s41512-019-0064-7 – volume: 15 start-page: 11 issue: 1 year: 2018 end-page: 24 ident: CR30 article-title: The inflammatory microenvironment and microbiome in prostate cancer development publication-title: Nat. Rev. Urol. doi: 10.1038/nrurol.2017.167 – ident: CR24 – year: 2019 ident: CR28 publication-title: Clinical Prediction Models doi: 10.1007/978-3-030-16399-0 – volume: 17 start-page: 32 issue: 1 year: 2019 end-page: 37 ident: CR35 article-title: Elevated serum cytokines and serology at diagnosis are not associated with higher Gleason grade or lethal prostate cancer publication-title: Clin. Genitourin. Cancer doi: 10.1016/j.clgc.2018.09.022 – volume: 6 start-page: 74 issue: 2 year: 2014 ident: 81965_CR13 publication-title: Ther. Adv. Urol. doi: 10.1177/1756287213513488 – volume: 17 start-page: 32 issue: 1 year: 2019 ident: 81965_CR35 publication-title: Clin. Genitourin. Cancer doi: 10.1016/j.clgc.2018.09.022 – volume: 21 start-page: 78 issue: 1 year: 2018 ident: 81965_CR12 publication-title: Prostate Cancer Prostatic Dis. doi: 10.1038/s41391-017-0008-7 – volume: 17 start-page: 2596 issue: 10 year: 2016 ident: 81965_CR20 publication-title: Cell Rep. doi: 10.1016/j.celrep.2016.11.010 – volume: 38 start-page: 2252 issue: 17 year: 2002 ident: 81965_CR33 publication-title: Eur. J. Cancer doi: 10.1016/S0959-8049(02)00218-6 – volume: 112 start-page: 943 issue: 5 year: 2015 ident: 81965_CR17 publication-title: Br. J. Cancer doi: 10.1038/bjc.2014.606 – ident: 81965_CR24 – volume-title: Categorical Data Analysis year: 2003 ident: 81965_CR36 – volume: 111 start-page: E592 issue: 5 year: 2014 ident: 81965_CR21 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1318157111 – volume: 389 start-page: 815 issue: 10071 year: 2017 ident: 81965_CR5 publication-title: The Lancet. doi: 10.1016/S0140-6736(16)32401-1 – volume: 129 start-page: e47 issue: 4 year: 2012 ident: 81965_CR31 publication-title: Thromb. Res. doi: 10.1016/j.thromres.2011.12.004 – volume: 4 start-page: 127rv3 issue: 127 year: 2012 ident: 81965_CR1 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3003180 – volume: 117 start-page: 409 issue: 3 year: 2016 ident: 81965_CR15 publication-title: BJU Int. doi: 10.1111/bju.13143 – year: 2018 ident: 81965_CR32 publication-title: Dis. Mark doi: 10.1155/2018/3852401 – volume: 47 start-page: 903 issue: 6 year: 2011 ident: 81965_CR3 publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2010.11.012 – volume: 134 start-page: 1697 issue: 22 year: 2016 ident: 81965_CR7 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.022802 – volume: 26 start-page: 565 issue: 6 year: 2006 ident: 81965_CR27 publication-title: Med. Decis. Making doi: 10.1177/0272989X06295361 – volume: 1 start-page: 999 issue: 9 year: 2016 ident: 81965_CR6 publication-title: JAMA Cardiol. doi: 10.1001/jamacardio.2016.3311 – volume: 15 start-page: 11 issue: 1 year: 2018 ident: 81965_CR30 publication-title: Nat. Rev. Urol. doi: 10.1038/nrurol.2017.167 – start-page: 153 volume-title: The Role of Inflammation in Prostate Cancer year: 2014 ident: 81965_CR18 doi: 10.1007/978-3-0348-0837-8_7 – volume: 109 start-page: 1480 issue: 10 year: 2012 ident: 81965_CR8 publication-title: BJU Int. doi: 10.1111/j.1464-410X.2011.10611.x – volume: 27 start-page: 363 issue: 4 year: 2006 ident: 81965_CR23 publication-title: J. Immunoassay Immunochem. doi: 10.1080/15321810600862298 – volume: 26 start-page: 421 issue: 3 year: 2017 ident: 81965_CR34 publication-title: Adv. Clin. Exp. Med. doi: 10.17219/acem/62120 – volume: 360 start-page: 1320 issue: 13 year: 2009 ident: 81965_CR4 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0810084 – volume: 61 start-page: 577 issue: 3 year: 2012 ident: 81965_CR9 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2011.11.012 – volume: 7 start-page: 450 issue: 01 year: 2008 ident: 81965_CR22 publication-title: J. Proteome Res. doi: 10.1021/pr070409o – volume: 44 start-page: 837 year: 1988 ident: 81965_CR26 publication-title: Biometrics doi: 10.2307/2531595 – volume: 3 start-page: 1 issue: 1 year: 2019 ident: 81965_CR29 publication-title: Diagn. Progn. Res. doi: 10.1186/s41512-019-0064-7 – volume: 120 start-page: 1045 issue: 11 year: 2019 ident: 81965_CR19 publication-title: Br. J. Cancer doi: 10.1038/s41416-019-0458-x – volume-title: Clinical Prediction Models year: 2019 ident: 81965_CR28 doi: 10.1007/978-3-030-16399-0 – volume: 64 start-page: 876 issue: 6 year: 2013 ident: 81965_CR2 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2013.05.049 – volume: 68 start-page: 464 issue: 3 year: 2015 ident: 81965_CR14 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2014.10.021 – volume: 30 start-page: 181 issue: 2 year: 2012 ident: 81965_CR11 publication-title: World J. Urol. doi: 10.1007/s00345-011-0818-5 – volume: 83 start-page: 1362 issue: 6 year: 2014 ident: 81965_CR10 publication-title: Urology doi: 10.1016/j.urology.2014.02.035 – volume: 65 start-page: 534 issue: 3 year: 2014 ident: 81965_CR16 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2012.11.014 – volume: 20 start-page: 1 issue: 1 year: 2020 ident: 81965_CR25 publication-title: BMC Med. Inform. Decis. Mak. doi: 10.1186/s12911-020-01174-2 |
| SSID | ssj0000529419 |
| Score | 2.3721085 |
| Snippet | Improved prostate cancer detection methods would avoid over-diagnosis of clinically indolent disease informing appropriate treatment decisions. The aims of... Abstract Improved prostate cancer detection methods would avoid over-diagnosis of clinically indolent disease informing appropriate treatment decisions. The... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2525 |
| SubjectTerms | 631/67/589/466 692/4025/1752 692/499 692/53/2421 Biomarkers Biopsy Decision making Humanities and Social Sciences Inflammation multidisciplinary Peripheral blood Prostate cancer Regression analysis Science Science (multidisciplinary) Ultrasound |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEC5kQfAivu11lQjeNGznMen0UcVlFfTkwp4MeaLg9iwzPQf_vVXpnnHH58Vj5wGh6kvXF1L1BeAZRrysglc8KK-5Frpwr3Pii7KIXQk--VqV9v6DOT3T784X51ee-qKcsEkeeDLcsYlChT6ZYHSvZZI-BF1M7krulM666nxizLtymJpUvWWvRT9XybTKHq8xUlE1mRTckooeV3uRqAr2_45l_pos-dONaQ1EJ7fg5swg2ctp5bfhWh7uwPXpTclvd-HT21kAAiczhA96_KLepDME2-aCUb09peSs1tg7LplnlF3O0FWUkYoDGdJYdknFIEhDsR1RsWIpjzVna7gHZydvPr4-5fMjCjwiGRu5iSXkNnb0JW0sOikVS2t6GdCcQvqCHEYUpYyNsV3kXsRsc9slPMdFhWTwPhwMyyE_BJZTRrKUDJEQbUTuS-sDadQF9AyebhsQW4O6OCuM00MXX1296VbWTU5w6ARXneBUA893cy4nfY2_jn5FftqNJG3s2oCIcTNi3L8Q08DR1stu3rBrJ7Ul4R8j2wae7rpxq9H9iR_yclPHIL9RSFobeDCBYrcSpfDnJg32dHtw2Vvqfs_w5XOV8-6spnNsAy-2wPqxrD-b4vB_mOIR3JC0I1rBpT2Cg3G1yY-RZI3hSd1P3wFufiOb priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k1KQUbiBlbjxzrJCQGiKkhwotKesPwEJJosu9kD_74zjjfV8ugxthM5nrH92TPzDSEvYMeL0lnJnLSKKa4SsyoGtkgL3yRng81RaZ8-69Mz9XG5WJYLt01xq9ytiXmhDoPHO_JjoVpkZtGifr36xTBrFFpXSwqN6-QGUpehS1ezbOY7FrRiKd6VWJlatscb2K8wpkxw1iKXHpN7-1Gm7f8X1vzbZfIPu2nejk7ukNsFR9I3k-Dvkmuxv0duTpklf98nXz8UGgh4mYISgdzPsz2dgsptzylG3aNjznoDteNALUUfcwoCQ79UaEgBzNIVhoQAGIVy0I01DXHMnlv9A3J28v7Lu1NWUikwD5BsZNonF2vf4JNofVJBSp9q3QmnRODCJkAyPEmpW-_rRey4j22smwCnOS8BEj4kB_3Qx8eExhABMgWNUERpHrtUW4dMda5TAs64FeG7ATW-8IxjuoufJtu7ZWsmIRgQgslCMLIiL-d3VhPLxpWt36Kc5pbIkJ0LhvU3Uyac0Z5L1wXttIJ-BWGdU0nHJsVGqqjgI0c7KZsybTfmUskq8nyuhgmHVhTbx2Gb2wDKkQBdK_JoUoq5J1LCEic01DR76rLX1f2a_sf3TOrdtApPsxV5tVOsy279fygOr_6LJ-SWQF2vORPtETkY19v4FEDU6J7lmXIB99Eakg priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKERIXRHkGWmQkbmARP9ZxjrCiaivBiUo9YfkJSG222s0e-PfMOA-0UJA4xh5HI884_pyZ-UzIK9jxkvROMi-dYoqrzJxKkS3yIjTZu-hKVdrHT_rkXJ1dLC72iJhqYUrSfqG0LJ_pKTvs7QY2GiwGE5wZJMFj8ha5jdTt6NVLvZz_q2DkSvF2rI-ppblh6M4eVKj6b8KXf6ZJ_hYrLVvQ8X1yb8SO9N2g7QHZS90Dcme4TfLHQ_LldKR-gMEUHAdsfVVi6BTcbHtFsdIek3HWG-jtV9RRzCunYCTMRQVBCgCWXmMZCABQaAd_WNOY-pKt1T0i58cfPi9P2Hh9AgsAw3qmQ_apDg0-CROyilKGXOtWeCUiFy4DeuFZSm1CqBep5SGZVDcRTnBBAgx8TPa7VZeeEppiApgUNcIPpXlqc-08stP5Vgk411aETxNqw8gtjldcXNoS45bGDkawYARbjGBlRV7PY64HZo1_Sr9HO82SyIpdGlbrr3b0EqsDl76N2msFekXhvFdZpyanRqqk4CWHk5XtuFQ3ViiDlD9a1BV5OXfDIsPIievSaltkANlIgKsVeTI4xayJlPBZExp6mh132VF1t6f7_q0QeTdG4Qm2Im8mx_ql1t-n4tn_iT8ndwX6fs2ZMIdkv19v0xEAqd6_KCvnJ3EHGHQ priority: 102 providerName: Springer Nature |
| Title | Integrating inflammatory serum biomarkers into a risk calculator for prostate cancer detection |
| URI | https://link.springer.com/article/10.1038/s41598-021-81965-3 https://www.ncbi.nlm.nih.gov/pubmed/33510263 https://www.proquest.com/docview/2482357620 https://www.proquest.com/docview/2483813083 https://pubmed.ncbi.nlm.nih.gov/PMC7844261 https://doaj.org/article/6c13b9d6b64942d2abb4f6e7fe734e43 |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dixMxEA_3geDL4berZ4ngm0Y3H012H0R65Y6zcIeohT4ZNl8q3G3vtlvw_nsn2W2lWgWfyiaTkmZmdn5pMr9B6AVEPM9NxYnhlSCCikAq4R0ZhqFVwVSuSllpZ-fydComs-FsB63KHfULuNi6tYv1pKbNxesf1zfvwOHfdinjxZsFBKGYKMYoKSJBHuG7aB8ik4qOetbD_Y7rm5WCln3uzPahG_Ep0fhvw55_XqH87Rw1haeTO-igx5V41BnCXbTj63voVldp8uY--vK-p4WAwRh-JtjBZTpfx2CCy0scs_DjRZ1mAb3tHFc43jnHoMB4TxUEMYBbfBVTRACcQjvYSoOdb9NNrvoBmp4cfx6fkr60ArEA0VoibTA-tyo-scIG4Ti3IZclM4I5yqoAyIYGzmVhbT70JbW-8LlysLuzHCDiQ7RXz2v_GGHvPEAoJyM0EZL6MuSVicx1phQM9rwZoqsF1bbnHY_lLy50Ov_mhe6UoEEJOilB8wy9XI-56lg3_il9FPW0loyM2alh3nzVvQNqaSk3pZNGCpiXY5UxIkivgldceAFfcrjSsl5ZoWaiiHRAkuUZer7uBgeMpypV7efLJAOohwOUzdCjzijWM-EcXnlMQo_aMJeNqW721N-_JZJvVYi4u83Qq5Vh_ZrW35fiyf-JP0W3WbT9nBJWHKK9tln6ZwCyWjNAu2qmBmh_NJp8msDn0fH5h4_QOpbjQfrjYpB86ycdlSfx |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLaqqRBcEDsDBYwEJ7Ca2I6THBCi0GqGtiOEWqknTLwBEk2GWYT6p_iNvOckUw1Lbz1O7Iwcv89v8dsIeQYSzwtTCWZEJZlMZWCV9I5lIbN5MJWrYlba4USNjuX7k-xkg_zqc2EwrLLniZFRu8biHfk2lwVWZlE8eT39wbBrFHpX-xYaLSz2_dlPMNnmr8bvgL7POd_bPXo7Yl1XAWZBO1kwZYPxic3xFy9skE4IGxJVciO5S3kVQKinQQhVWJtkvkytL3ySOzBsrMjwAhRY_qYUYMoMyObO7uTDx9WtDvrNZFp22TmJKLbnICExi42nrMDqfUysScDYKOBf2u3fQZp_eGqjANy7Qa53mit900LtJtnw9S1ype1leXabfBp3hSfgZQqwBaSdRg8-BZAvTynm-WMo0GwOo4uGVhSj2ilABCNhYSIF9ZlOMQkF1F94DmicUecXMVasvkOOL2Wb75JB3dT-PqHeeVDSnELlR6rUlyGpDNbGM6XkYFUPSdpvqLZdZXNssPFdRw-7KHRLBA1E0JEIWgzJi9U707aux4Wzd5BOq5lYkzs-aGZfdHfEtbKpMKVTRklYl-OVMTIonwefC-kl_MlWT2XdMYq5Pof1kDxdDcMRR79NVftmGeeAXiVAWR6Sey0oVisRApgqVzCSr8FlbanrI_W3r7GMeF5ItJ-H5GUPrPNl_X8rHlz8FU_I1dHR4YE-GE_2H5JrHHGfpIwXW2SwmC39I1DhFuZxd24o-XzZR_U3OUhYhQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIhAXxJuFAkaCE1gbP-IkB4SAsupSqDhQaU-Y-AWV2uyyD6H-NX4dM06y1fLorceNnZXj-cYz43kR8hQkXpC2lszKWjHFVWS1Cp7lMXdFtLWvU1baxwO9d6jeT_LJFvnV58JgWGV_JqaD2k8d3pEPhSqxMosW2TB2YRGfdkevZj8YdpBCT2vfTqOFyH44_Qnm2-LleBdo_UyI0bvPb_dY12GAOdBUlky7aEPmCvwlSheVl9LFTFfCKuG5qCMIeB6l1KVzWR4q7kIZssKDkeNkjpehcPxfKmTOkceKSbG-30EPmuJVl6eTyXK4AFmJ-WyCsxLr-DG5IQtTy4B_6bl_h2v-4bNNonB0nVzrdFj6ugXdDbIVmpvkctvV8vQW-TLuSlDAyxQADJg7Sb58CnBfnVDM-MegoPkCRpdTWlOMb6cAFoyJhYkUFGk6w3QUUIThOeByTn1Ypqix5jY5vJBNvkO2m2kT7hEafAB1zWtUg5TmoYpZbbFKnq2UAPt6QHi_ocZ1Nc6x1caxSb52WZqWCAaIYBIRjByQ5-t3Zm2Fj3Nnv0E6rWdide70YDr_ZjpmN9pxaSuvrVawLi9qa1XUoYihkCoo-JOdnsqmOzIW5gzgA_JkPQzMjh6cugnTVZoDGpYEtXlA7ragWK9EAgjBoIaRYgMuG0vdHGmOvqeC4kWp0JIekBc9sM6W9f-tuH_-VzwmV4BBzYfxwf4DclUg7DPORLlDtpfzVXgIutzSPkpMQ8nXi-bS33jPW1U |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Integrating+inflammatory+serum+biomarkers+into+a+risk+calculator+for+prostate+cancer+detection&rft.jtitle=Scientific+reports&rft.au=Jalali%2C+Amirhossein&rft.au=Kitching%2C+Michael&rft.au=Martin%2C+Kenneth&rft.au=Richardson%2C+Ciaran&rft.date=2021-01-28&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-021-81965-3&rft.externalDocID=10_1038_s41598_021_81965_3 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |